⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7848073 | 0.72 | — | — | |
| SCHEMBL3411630 | 0.67 | — | — | |
| SCHEMBL459630 | 0.62 | — | — | |
| SCHEMBL9874604 | 0.61 | — | — | |
| Hydrochloric Acid SCHEMBL28941852 | 0.60 | — | — | |
| SCHEMBL136969 | 0.57 | — | — | |
| SCHEMBL28774597 | 0.57 | TDP1 (0.50) | — | |
| SCHEMBL1889832 | 0.57 | — | — | |
| SCHEMBL270019 | 0.57 | — | — | |
| SCHEMBL11569766 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3409762-A1 | COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS | The Scripps Research Institute (US) | 2018-12-05 | — | — | EP | disclosed |
| EP-2955222-B1 | COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS | SCRIPPS RESEARCH INST (US) | 2018-09-12 | — | — | EP | disclosed |
| US-20180171303-A1 | COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS | THE SCRIPPS RESEARCH INSTITUTE | 2018-06-21 | — | — | US | disclosed |
| US-9926533-B2 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells | THE SCRIPPS RESEARCH INSTITUTE (US) | 2018-03-27 | — | — | US | disclosed |
| US-20180002671-A1 | CHEMICAL APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS | THE SCRIPPS RESEARCH INSTITUTE | 2018-01-04 | — | — | US | disclosed |
| US-9771563-B2 | Chemical approaches for generation of induced pluripotent stem cells | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-09-26 | — | — | US | disclosed |
| US-20170081640-A1 | COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS | THE SCRIPPS RESEARCH INSTITUTE | 2017-03-23 | — | — | US | disclosed |
| US-9540615-B2 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-01-10 | — | — | US | disclosed |
| US-9534205-B2 | Combined chemical and genetic approaches for generation of induced pluripotent stem cells | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-01-03 | — | — | US | disclosed |
| US-20160369244-A1 | CHEMICAL APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS | THE SCRIPPS RESEARCH INSTITUTE | 2016-12-22 | — | — | US | disclosed |
| US-20040087583-A1 | Amino-thio-acrylonitriles as MEK inhibitors | HOBBS FRANK WORDEN (US) | 2004-05-06 | — | — | US | disclosed |
| US-20040087583-A1 | Amino-thio-acrylonitriles as MEK inhibitors | HOBBS FRANK WORDEN (US) | 2004-05-06 | — | — | US | disclosed |
| US-6703420-B1 | MITOGEN ACTIVATED PROTEIN KINASE (MAPK) INHIBITORS; ANTIINFLAMMATORY, ANTICARCINOGENIC, OR ANTIPROLIFERATIVE AGENTS; RADIOSENSITIZERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-09 | — | — | US | disclosed |
| US-6703420-B1 | MITOGEN ACTIVATED PROTEIN KINASE (MAPK) INHIBITORS; ANTIINFLAMMATORY, ANTICARCINOGENIC, OR ANTIPROLIFERATIVE AGENTS; RADIOSENSITIZERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-09 | — | — | US | disclosed |
| US-6703420-B1 | MITOGEN ACTIVATED PROTEIN KINASE (MAPK) INHIBITORS; ANTIINFLAMMATORY, ANTICARCINOGENIC, OR ANTIPROLIFERATIVE AGENTS; RADIOSENSITIZERS | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-03-09 | — | — | US | disclosed |
| EP-1163215-A1 | AMINO-THIO-ACRYLONITRILES AS MEK INHIBITORS | Du Pont Pharmaceuticals Company (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-1163215-A1 | AMINO-THIO-ACRYLONITRILES AS MEK INHIBITORS | Du Pont Pharmaceuticals Company (US) | 2001-12-19 | — | — | EP | disclosed |
| US-6214851-B1 | AND A METHOD FOR TREATING OR PREVENTING A DISORDER RELATED TO MEK;ANTIINFLAMATORY,ANTICANCER AGENTS | DUPONT PHARMACEUTICALS COMPANY | 2001-04-10 | — | — | US | disclosed |
| WO-2000056706-A1 | AMINO-THIO-ACRYLONITRILES AS MEK INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-09-28 | — | — | WO | disclosed |
| WO-2000056706-A1 | AMINO-THIO-ACRYLONITRILES AS MEK INHIBITORS | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-09-28 | — | — | WO | disclosed |